title: 2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (update on dabigatran): a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines.
authors.forename: L Samuel
authors.initials: LS
authors.lastname: Wann
authors.forename: Anne B
authors.initials: AB
authors.lastname: Curtis
authors.forename: Kenneth A
authors.initials: KA
authors.lastname: Ellenbogen
authors.forename: N A Mark
authors.initials: NA
authors.lastname: Estes
authors.forename: Michael D
authors.initials: MD
authors.lastname: Ezekowitz
authors.forename: Warren M
authors.initials: WM
authors.lastname: Jackman
authors.forename: Craig T
authors.initials: CT
authors.lastname: January
authors.forename: James E
authors.initials: JE
authors.lastname: Lowe
authors.forename: Richard L
authors.initials: RL
authors.lastname: Page
authors.forename: David J
authors.initials: DJ
authors.lastname: Slotwiner
authors.forename: William G
authors.initials: WG
authors.lastname: Stevenson
authors.forename: Cynthia M
authors.initials: CM
authors.lastname: Tracy
mesh_terms: D026683:Advisory Committees / Q000592:standards* / Q000639:trends; D000572:American Heart Association; D001281:Atrial Fibrillation / Q000188:drug therapy* / Q000628:therapy; D001562:Benzimidazoles / Q000627:therapeutic use*; D002309:Cardiology / Q000592:standards* / Q000639:trends; D000069604:Dabigatran; D019468:Disease Management; D006801:Humans; D012955:Societies, Medical / Q000592:standards / Q000639:trends; D014481:United States; D015091:beta-Alanine / Q000031:analogs & derivatives* / Q000627:therapeutic use
chemical_list: D001562:Benzimidazoles; D015091:beta-Alanine; D000069604:Dabigatran